Tuyen Ong - 04 Oct 2021 Form 4/A - Amendment Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4/A - Amendment
Accepted by SEC
09 Mar 2022, 17:14:33 UTC
Original report date
06 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian Piekos, attorney-in-fact

Key filing fact

Tuyen Ong filed Form 4/A - Amendment for Gemini Therapeutics, Inc. /DE (IRON) on 09 Mar 2022.

Key facts

  • This page summarizes Tuyen Ong's Form 4/A - Amendment filing for Gemini Therapeutics, Inc. /DE (IRON).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 09 Mar 2022, 17:14.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+15,528
Change %
Price
$0.000000
Shares after
15,528
Date
04 Oct 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,528
Exercise price
$3.80
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.

SEC remarks

This Form 4/A amends and restates the original Form 4 filed on October 6, 2021 to correct the number of stock options granted to the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .